Latest BioPharma News and In-Depth Analysis

Exactech Boosts AI Capabilities with Exclusive Machine-Learning Software Licensing Agreement and Data Scientist Team

Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced today it has ex...

March 28, 2023 | Tuesday | News

Healthcare in the post-COVID era: accessible, rapid and tech-driven

The permanent shift in consumer preferences, rising expectations for enhanced customer experiences (CX) and digital transformation, driven by COVID-19, hav...

March 26, 2023 | Sunday | Opinion

Enhanced traceability plays a crucial role in building a resilient biopharma supply chain

How do you foresee digitalisation trends in APAC pharmaceutical supply chain improvising visibility, agility, and business resilience? Unpredict...

March 26, 2023 | Sunday | Influencers

Lunit to Supply AI Solution for Chest X-Ray Analysis to Albert Einstein, Latin America's Largest Hospital

Lunit signed a software license agreement with the Hospital Israelita Albert Einstein, Latin America's top medical institution, to provide its AI-based c...

January 05, 2023 | Thursday | News

Partner Content

Idorsia Initiates Phase 2 Trial of First-in-Class Oral CCR6 Antagonist in Psoriasis
07 January, 2026
Fagron Completes Acquisition of Purifarma in Brazil
07 January, 2026
FUJIFILM Biosciences Name Change Takes Effect As Life Sciences Group Restructuring Moves Into Execution
06 January, 2026
Hoth Therapeutics Files Two U.S. Provisional Patents to Establish Oncology-Focused Dermatology Platform
06 January, 2026
MindRank Initiates Pivotal Phase III Trial for AI-Designed Oral GLP-1 Candidate MDR-001
07 January, 2026
Eisai and Biogen Secure NMPA Acceptance for Subcutaneous LEQEMBI in China
07 January, 2026

BioPharma BreakThrough's

SciSparc-Backed NeuroThera Secures Israeli Patent for Opioid–N-Acylethanolamine Combination Therapy
01 January, 2026
Palisade Bio Secures Japanese Patent for Gut-Targeted PDE4 Inhibitor PALI-2108
01 January, 2026
Vanda Pharmaceuticals’ Tradipitant (NEREUS™) Approved by FDA for Motion-Induced Vomiting
01 January, 2026
Tiger BioSciences Strengthens Clinical Leadership With Expanded Evidence-Based Research in 2025
01 January, 2026
Transcenta Therapeutics Enters Strategic Bioprocessing Collaboration With EirGenix
31 December, 2025
Mabwell Doses First Patient in World’s First Phase II Trial of Anti-IL-11 Antibody for Pathological Scarring
01 January, 2026

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

Gene Editing Breakthroughs

Innovative Drug Discovery

Vaccine Development

Biologics and Therapeutic Antibodies

× Please select an option to participate in the poll.

View poll results More polls

× You have successfully cast your vote.

{{ optionDetail.option }} {{ optionDetail.percentage }}%

More polls

March 28, 2023 | Tuesday | News

March 26, 2023 | Sunday | Opinion

March 26, 2023 | Sunday | Influencers

January 05, 2023 | Thursday | News